- Home
- HSTM vs SANA Comparison
HSTM vs SANA Comparison
Compare HSTM & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSTM
- SANA
- Stock Information
- Founded
- HSTM 1990
- SANA 2018
- Country
- HSTM United States
- SANA United States
- Employees
- HSTM N/A
- SANA N/A
- Industry
- HSTM Computer Software: Programming Data Processing
- SANA Medicinal Chemicals and Botanical Products
- Sector
- HSTM Technology
- SANA Health Care
- Exchange
- HSTM Nasdaq
- SANA Nasdaq
- Market Cap
- HSTM 864.6M
- SANA 983.4M
- IPO Year
- HSTM 2000
- SANA 2021
- Fundamental
- Price
- HSTM $26.95
- SANA $4.12
- Analyst Decision
- HSTM Hold
- SANA Strong Buy
- Analyst Count
- HSTM 2
- SANA 6
- Target Price
- HSTM $28.00
- SANA $8.00
- AVG Volume (30 Days)
- HSTM 191.3K
- SANA 3.8M
- Earning Date
- HSTM 10-20-2025
- SANA 11-07-2025
- Dividend Yield
- HSTM 0.46%
- SANA N/A
- EPS Growth
- HSTM 14.03
- SANA N/A
- EPS
- HSTM 0.67
- SANA N/A
- Revenue
- HSTM $295,211,000.00
- SANA N/A
- Revenue This Year
- HSTM $4.90
- SANA N/A
- Revenue Next Year
- HSTM $5.12
- SANA N/A
- P/E Ratio
- HSTM $40.24
- SANA N/A
- Revenue Growth
- HSTM 3.50
- SANA N/A
- 52 Week Low
- HSTM $25.36
- SANA $1.26
- 52 Week High
- HSTM $34.24
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- HSTM 35.07
- SANA 68.83
- Support Level
- HSTM $27.04
- SANA $3.28
- Resistance Level
- HSTM $27.94
- SANA $3.58
- Average True Range (ATR)
- HSTM 0.56
- SANA 0.23
- MACD
- HSTM -0.29
- SANA 0.11
- Stochastic Oscillator
- HSTM 1.09
- SANA 90.98
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.